133 related articles for article (PubMed ID: 3522050)
21. Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxemia.
Schaller MD; Waeber B; Nussberger J; Brunner HR
Am J Physiol; 1985 Dec; 249(6 Pt 2):H1086-92. PubMed ID: 3907375
[TBL] [Abstract][Full Text] [Related]
22. Evidence for independent actions of vasopressin on renal inner medullary cyclic AMP and prostaglandin E production: relationship of the prostaglandin E response to hormone pressor activity.
Campbell HT; Craven PA; DeRubertis FR
Metabolism; 1982 Oct; 31(10):1035-41. PubMed ID: 6290836
[TBL] [Abstract][Full Text] [Related]
23. Chemical renal medullectomy: effect on blood pressure in normal rats.
Taverner D; Fletcher A; Russell GI; Bing RF; Jackson J; Swales JD; Thurston H
J Hypertens Suppl; 1983 Dec; 1(2):43-5. PubMed ID: 6599495
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
Tarpey SB; Bennett T; Randall MD; Gardiner SM
Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
[TBL] [Abstract][Full Text] [Related]
25. In vivo diuretic actions of renal vasopressin V1 receptor stimulation in rats.
Ledderhos C; Mattson DL; Skelton MM; Cowley AW
Am J Physiol; 1995 Mar; 268(3 Pt 2):R796-807. PubMed ID: 7900923
[TBL] [Abstract][Full Text] [Related]
26. Blood pressure and heart rate effect of a vasopressin antagonist in conscious normotensive rats pretreated with exogenous vasopressin.
Waeber B; Nussberger J; Brunner HR
Eur J Pharmacol; 1983 Jul; 91(1):135-7. PubMed ID: 6688586
[TBL] [Abstract][Full Text] [Related]
27. Control of renal medullary blood flow by vasopressin V1 and V2 receptors.
Nakanishi K; Mattson DL; Gross V; Roman RJ; Cowley AW
Am J Physiol; 1995 Jul; 269(1 Pt 2):R193-200. PubMed ID: 7631893
[TBL] [Abstract][Full Text] [Related]
28. Vasodepressor mechanisms in experimental hypertension: studies using chemical medullectomy.
Swales JD; Bing RF; Russell GI; Taverner D; Thurston H
J Hypertens Suppl; 1986 Oct; 4(4):S43-6. PubMed ID: 3534184
[TBL] [Abstract][Full Text] [Related]
29. Evidence for a functional relationship between noradrenaline and neurohypophyseal peptides in the brainstem of rats.
Vallejo M; Lightman SL
Brain Res; 1987 Oct; 422(2):295-302. PubMed ID: 3676790
[TBL] [Abstract][Full Text] [Related]
30. Contribution of vasopressin and the sympathetic nervous system in the early phase of high sodium one-kidney renal hypertension.
Hinojosa C; Haywood JR
Hypertension; 1984; 6(6 Pt 1):848-54. PubMed ID: 6240442
[TBL] [Abstract][Full Text] [Related]
31. Antagonism of vasopressin-induced coronary artery constriction by the vasopressin antagonist d(CH2)5Tyr(Me)-AVP.
Kopia GA; Valocik RE
J Cardiovasc Pharmacol; 1985; 7(5):958-63. PubMed ID: 2413308
[TBL] [Abstract][Full Text] [Related]
32. Acute aortic coarctation hypertension: role of vasopressin and angiotensin II.
Salgado HC; Salgado MC
Am J Physiol; 1989 Nov; 257(5 Pt 2):H1480-4. PubMed ID: 2589503
[TBL] [Abstract][Full Text] [Related]
33. Influence of arginine vasopressin receptors and angiotensin receptor subtypes on the water intake and arterial blood pressure induced by vasopressin injected into the lateral septal area of the rat.
Abrão Saad W; Antonio De Arruda Camargo L; Sérgio Cerri P; Simões S; Abrão Saad W; Garcia G; Izabel Gutierrez L; Guarda I; Saad Guarda R
Auton Neurosci; 2004 Mar; 111(1):66-70. PubMed ID: 15109940
[TBL] [Abstract][Full Text] [Related]
34. Prolonged inhibition of pressor response to vasopressin by a potent specific antagonist, [1-(beta-mercapto-beta, beta-cyclopentamethylenepropionic acid) 2-(O-methyl)tyrosine]arginine-vasopressin.
Pang CC; Leighton KM
Can J Physiol Pharmacol; 1981 Sep; 59(9):1008-12. PubMed ID: 6895346
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular effects of injections of vasopressin into the nucleus tractus solitarius in conscious rats.
King KA; Pang CC
Br J Pharmacol; 1987 Mar; 90(3):531-6. PubMed ID: 3567458
[TBL] [Abstract][Full Text] [Related]
36. Effect of arginine vasopressin on renal medullary blood flow. A videomicroscopic study in the rat.
Zimmerhackl B; Robertson CR; Jamison RL
J Clin Invest; 1985 Aug; 76(2):770-8. PubMed ID: 4031072
[TBL] [Abstract][Full Text] [Related]
37. Chemical renal medullectomy. Effect on urinary prostaglandin E2 and plasma renin in response to variations in sodium intake and in relation to blood pressure.
Bing RF; Russell GI; Thurston H; Swales JD; Godfrey N; Lazarus Y; Jackson J
Hypertension; 1983; 5(6):951-7. PubMed ID: 6360871
[TBL] [Abstract][Full Text] [Related]
38. Nitric oxide in the renal medulla protects from vasopressin-induced hypertension.
Szentiványi M; Park F; Maeda CY; Cowley AW
Hypertension; 2000 Mar; 35(3):740-5. PubMed ID: 10720588
[TBL] [Abstract][Full Text] [Related]
39. DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin?
Derkx FH; Man in 't Veld AJ; Jones R; Reid JL; Schalekamp MA
J Hypertens Suppl; 1983 Dec; 1(2):58-61. PubMed ID: 6400119
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of pressor effects of intraventricular injection of angiotensin II in the rat: role of vasopressin and renal nerves.
Suzuki H; Kondo K; Handa M; Kawabe H; Saruta T
Clin Sci (Lond); 1982 Sep; 63(3):275-9. PubMed ID: 7047051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
